Obesity, Diabetes Increases Risk of Chest Wall Pain from SBRT

AuntMinnie | Stereotactic body radiation therapy (SBRT) is increasingly being used to treat lung cancer patients with for whom surgery is not an option. But overweight and diabetic patients have a greater risk of developing chest wall pain, according to a study published in the September issue of the International Journal of Radiation Oncology, Biology, Physics.

Thoracic radiation oncologists and medical physicists at the University of Texas MD Anderson Cancer Center analyzed the toxicities experienced by 265 patients who had pulmonary tumors within 2.5 cm of the chest wall. All received SBRT between August 2004 and August 2008, which consisted of a total radiation dose of 50 Gy in four daily 12.5-Gy fractions (Int J Radiat Oncol Biol Phys, September 2011, Vol. 81:1, pp. 91-96).

The objective of the study was to identify the characteristics that could be associated with chest wall pain and skin toxicities experienced by patients with primary or metastatic lung disease. The median distance between the tumor being treated and the chest wall was 0.59 cm, with a range of 0 to 2.47 cm. The patients were predominantly elderly, with a median age of 73 years, but were as young as 43 years of age. They were followed for a median of 10.3 months.

Assistant professor of radiation oncology Dr. James W. Welsh and colleagues calculated the absolute volumes of the chest wall receiving 10, 20, 30, 40, and 50 Gy, then compared them with the development of chest pain and skin toxicity. They also evaluated whether using immobilization devices during SBRT could contribute to an increased skin dose.

The research team determined that the thickness of a stereotactic immobilization bag affected skin dose, with a 1.5-cm bag increasing the dose by 23% and a 6.0-cm bag increasing the dose by 41%. They also compared an “unspoiled” radiation beam to one delivered through the treatment couch, which caused an increased skin dose up to 49%.

Toxicities Experienced

The researchers found that 39% of patients developed skin toxicity. Patients who had a gross tumor volume of 8 mL or more were almost two times more likely to develop a skin reaction, and patients who had a posterior lesion were one and a half times more likely. But patients whose chest wall received at least 30 Gy of radiation dose had the highest likelihood of having a skin reaction, at almost three times more than patients who did not.

One-fourth of patients developed chest wall pain within 11 months of treatment. Eight patients had rib fractures and 14 patients developed acute pain. An additional 45 patients developed chronic pain, almost equally divided between grade 1 and grade 2. Patients whose chest wall received at least 30 Gy of radiation dose were more susceptible, at a rate of 18% compared with those who had received less at 2.7%.

Of the patients with a body mass index of 29 or more, 27% experienced chest wall pain — more than twice the percentage of thinner patients. More than half of these patients had diabetes mellitus. Based on these findings, the authors suggested that radiation oncologists may wish to be more conservative when treating obese patients, particularly those who also have diabetes.

Read more on AuntMinnie.com.



Kyle Henneberry, M.D.

Associate Chief Medical Officer
Dr. Kyle Henneberry is a radiologist, health-tech innovator and one of the founders and principals of Direct Radiology. A native of Spokane, Washington, he graduated with honors in Biomedical Engineering from Northwestern University, received his medical degree from Case Western Reserve University in Cleveland, Ohio, and completed radiology residency at the University of Colorado. Dr. Henneberry has United States, Europe, Australia, and New Zealand.

Jerry Lee

Chief Technology Officer

Jerry Lee has over 25 years of experience in healthcare IT. and has been with ONRAD since 2013. As the CTO, he is responsible for developing the organization’s technology strategy including IT infrastructure, application development, data analytics, cybersecurity and overall risk management. Lee’s focus is on strategic road mapping, leveraging emerging technologies and business intelligence to automate, streamline and optimize business processes. He previously worked as a senior healthcare IT consultant, where he implemented best practices, policies & procedures, and risk mitigation strategies for a variety of clients. He also previously worked as the Business Intelligence and Analytics Project Manager for a leading healthcare SaaS organization. He graduated with a B.S. from the University of California, Irvine.

Leandra Hutchinson

President, Direct Radiology

Leandra Hutchinson joined ONRAD alongside the acquisition of Direct Radiology in December 2024. Hutchison has broad experience in the healthcare industry, spending her career in healthcare technology and innovation. Prior to joining Direct Radiology in 2019, Leandra was the co-founder and Vice President of Operations of a health-tech company specializing in radiology analytics and healthcare asset management. Previously, Leandra worked in marketing, strategy, and operations roles for more than 10 years at a $7B integrated delivery system of hospitals and medical centers with more than 900 employed physicians. Hutchison earned her Bachelor’s degree from Kent State University and graduate certificate in health care policy and administration and MBA from the University of Toledo.

Ron Jackson

President, AllRads

Ron Jackson serves as President of AllRads at ONRAD, bringing over 30 years of comprehensive healthcare leadership across the provider, payer, and technology landscape. With deep expertise in radiology, he has spent more than 25 years in revenue cycle management, operations, finance, and practice management roles at leading organizations including HBOC, Per-Se Technologies, McKesson, and Zotec Partners. At ONRAD, Jackson leads day-to-day operations and strategic execution of AllRads, drawing on his cross-functional experience to drive efficiency, scalability, and growth. His 360-degree perspective of the healthcare ecosystem uniquely positions him to align organizational strategy with market dynamics in teleradiology and imaging services.

Alix Vincent, M.D.

Chief Medical Officer

Dr. Alix Vincent was one of the founding physicians at ONRAD. With over 26 years of radiology leadership experience, Dr. Vincent oversees medical staff activities, including patient safety, quality, and risk management initiatives. He manages ONRAD’s Regional Medical Directors, evaluates staff physicians, and drives clinical improvements to enhance physician alignment within the organization. Additionally, Dr. Vincent leads medical operations and played a key role in developing the company’s PACS and RIS Network capabilities. He previously served as Chief Radiologist and Chairman of the Radiology Department at Riverside Regional Medical Center. Dr. Vincent holds an M.D. in Radiology from Loma Linda University.

Lyn Mize

Chief Financial Officer

Lyn Mize serves as Chief Financial Officer at ONRAD, a role she has held since June 2022. With over two decades of experience in financial leadership, Mize has held CFO positions at various healthcare organizations, including Sunset Media Entertainment and Oncology Convergence, Inc. She also served as Vice President of Accounting at Health Choice and System Director of Accounting at Scottsdale Healthcare. Mize has a strong background in financial management, having worked with Banner Health and Greeley Medical Clinic, where she provided financial leadership for multi-specialty clinics and physician networks. Mize holds extensive expertise in driving financial performance and strategic growth across the healthcare sector and has a B.S. from DeVry University and a Masters from Grand Canyon University.

Dave Engert

President & CEO

Dave Engert started at Onrad as President and CEO in 2017. Engert is a seasoned healthcare executive with over 35 years of experience and a proven track record of leading and transforming healthcare technology organizations to drive growth and improve operational and financial performance. He previously served as President and CEO of Nighthawk Radiology, the largest teleradiology provider, and led its successful sale to vRad. Engert also held the role of President and CEO of Quality Care Solutions (QCSI), a leading provider of health insurance software, which was sold to Trizetto. Additionally, he has held leadership roles at McKesson, HBOC, and other notable companies and invested in several healthcare technology ventures. Engert holds a B.S. in Industrial Engineering from Louisiana State University.